Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 41-50 of 53
Item hits:
Issue DateTitleAuthor(s)
4-Jun-2018A global perspective on vasoactive agents in shockAnnane, D; Ouanes-Besbes, L; De Backer, D; Du, B; Gordon, AC, et al
3-Jul-2019Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Statistical and Health Economic Analysis Plan for the 65 trialThomas, K; Patel, A; Sadique, MZ; Grieve, RD; Mason, AJ, et al
1-Aug-2018Sepsis: who will shoot first? Pharma or diagnostics?Textoris, J; Gordon, AC
Nov-2019Terlipressin or norepinephrine, or both in septic shock?MÃ¥rtensson, J; Gordon, AC; National Institute for Health Research; National Institute for Health Research
1-Dec-2018Innovation and safety in critical care: should we collaborate with the industry? YesGordon, AC; Russell, JA
7-May-2019Methodological challenges in European ethics approvals for a genetic epidemiology study in critically ill patients: The GenOSept experienceTridente, A; Holloway, PAH; Hutton, P; Gordon, AC; Mills, GH, et al
3-Jun-2019Why understanding sepsis endotypes is important for steroid trials in septic shock?Antcliffe, DB; Gordon, AC; Imperial College Healthcare NHS Trust- BRC Funding; Imperial College Healthcare NHS Trust- BRC Funding
3-May-2019Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trialsSanthakumaran, S; Gordon, AC; Prevost, A; O'Kane, C; McAuley, DF, et al
22-Oct-2018The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive careKomorowski, M; Celi, LA; Badawi, O; Gordon, AC; Faisal, A, et al
Oct-2019Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trialAntcliffe, DB; Santhakumaran, S; Orme, RML; Ward, JK; Al-Beidh, F, et al